AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7846220 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive indices of sympathetic (preejection period) and parasympathetic (respiratory sinus arrhythmia) control
Number of subjects: 0
Study 3508327 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg twice daily for 2 weeks
Number of subjects: 34
Study 3508327 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 750 mg twice daily for 2 weeks
Number of subjects: 34
Study 3508327 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 375 mg twice daily for 2 weeks (continued from phase I)
Number of subjects: 34
Study 30324562 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride (SDF)
Number of subjects: 120
Study 30324562 — intervention group
Group type: COMPARATOR
Intervention: Control (no SDF)
Number of subjects: 120
Study 28294471 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom‐Associated Tension (SAT) training
Number of subjects: 60
Study 28294471 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoventilation Respiratory Training (HRT)
Number of subjects: 60
Study 28294471 — intervention group
Group type: COMPARATOR
Intervention: Relaxation Skills Training (RST)
Number of subjects: 60
Study 26262016 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app with notifications during 'message-on' periods
Number of subjects: 27
Study 26262016 — intervention group
Group type: COMPARATOR
Intervention: Control group with no notifications during 'message-off' periods
Number of subjects: 27
Study 24075465 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 34
Study 24075465 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 34
Study 21959572 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermasilk briefs
Number of subjects: 42
Study 21959572 — intervention group
Group type: COMPARATOR
Intervention: Cotton briefs (placebo)
Number of subjects: 42
Study 18248107 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking in place for 3 minutes
Number of subjects: 102
Study 18248107 — intervention group
Group type: COMPARATOR
Intervention: Sitting still for 3 minutes (Control)
Number of subjects: 102
Study 16766483 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light with a red filter
Number of subjects: 10
Study 16766483 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light with a yellow filter
Number of subjects: 10
Study 16766483 — intervention group
Group type: EXPERIMENTAL
Intervention: 810 nm diode laser
Number of subjects: 10
Study 16766483 — intervention group
Group type: EXPERIMENTAL
Intervention: 755 nm alexandrite laser
Number of subjects: 10
Study 16766483 — intervention group
Group type: COMPARATOR
Intervention: Control non-treated area
Number of subjects: 10
Study 14978133 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy (Phleum pratense, Phl P) for 2 years
Number of subjects: 0
Study 14978133 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 0
Study 14978133 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-immunotherapy serum
Number of subjects: 0
Study 10768243 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-eradication therapy
Number of subjects: 20
Study 10768243 — intervention group
Group type: COMPARATOR
Intervention: Persistent HP-positive patients
Number of subjects: 20
Study 10768243 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful retherapy for persistent HP-positive patients
Number of subjects: 20
Study 10768243 — intervention group
Group type: COMPARATOR
Intervention: Patients with gastroesophageal reflux disease
Number of subjects: 20
Study 9351692 — intervention group
Group type: EXPERIMENTAL
Intervention: CORTEX X1
Number of subjects: 15
Study 8222742 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release metoclopramide ('Gastrobid Continus' tablets) 15 mg given twice daily
Number of subjects: 20
Study 8222742 — intervention group
Group type: COMPARATOR
Intervention: Normal-release metoclopramide ('Maxolon') 10 mg given 4-times daily
Number of subjects: 20
Study 8222742 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release metoclopramide
Number of subjects: 20
Study 8222742 — intervention group
Group type: COMPARATOR
Intervention: Normal-release metoclopramide
Number of subjects: 20
Study 3544647 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine (n = 20)
Number of subjects: 40
Study 3544647 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 40
Study 29471076 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning energy distribution (50% kcal at breakfast, 30% at lunch, 20% at dinner)
Number of subjects: 8
Study 29471076 — intervention group
Group type: COMPARATOR
Intervention: Evening energy distribution (20% kcal at breakfast, 30% at lunch, 50% at dinner)
Number of subjects: 8
Study 30351770 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy during AVF puncture
Number of subjects: 30
Study 30351770 — intervention group
Group type: COMPARATOR
Intervention: No cryotherapy (Control)
Number of subjects: 30
Study 25502137 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity mannequins
Number of subjects: 54
Study 25502137 — intervention group
Group type: COMPARATOR
Intervention: Mid-fidelity mannequins
Number of subjects: 54
Study 25502137 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity mannequins
Number of subjects: 54
Study 22788576 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic acupuncture
Number of subjects: 204
Study 22788576 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (control)
Number of subjects: 204
Study 22788576 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Authentic and Sham acupuncture)
Number of subjects: 204
Study 22788576 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic acupuncture with low-calorie diet
Number of subjects: 204
Study 20015104 — intervention group
Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 90 mg
Number of subjects: 32
Study 20015104 — intervention group
Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 60 mg
Number of subjects: 32
Study 20015104 — intervention group
Group type: EXPERIMENTAL
Intervention: S-tenatoprazole-Na 30 mg
Number of subjects: 32
Study 20015104 — intervention group
Group type: COMPARATOR
Intervention: Esomeprazole 40 mg
Number of subjects: 32
Study 18298359 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking on a treadmill at 60% heart rate reserve
Number of subjects: 18
Study 18298359 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking on a treadmill at increasing intensities
Number of subjects: 18
Study 16209675 — intervention group
Group type: EXPERIMENTAL
Intervention: Merocel
Number of subjects: 52
Study 16209675 — intervention group
Group type: EXPERIMENTAL
Intervention: RapidRhino
Number of subjects: 52
Study 12620168 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (single or combination)
Number of subjects: 0
Study 12620168 — intervention group
Group type: COMPARATOR
Intervention: Control (no diuretics)
Number of subjects: 0
Study 10776741 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 160 mg daily
Number of subjects: 17444
Study 10776741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17444
Study 8849769 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer screening
Number of subjects: 0
Study 1359319 — intervention group
Group type: EXPERIMENTAL
Intervention: FK‐224 (4 mg)
Number of subjects: 10
Study 1359319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1359319 — intervention group
Group type: EXPERIMENTAL
Intervention: FK‐224
Number of subjects: 10
Study 3925929 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (600 mg)
Number of subjects: 5
Study 3925929 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (100 mg)
Number of subjects: 5
Study 3925929 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (1500-2000 mg)
Number of subjects: 5
Study 3925929 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (800 mg)
Number of subjects: 5
Study 3925929 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 5
Study 31517976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 48
Study 31517976 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study 29330573 — intervention group
Group type: COMPARATOR
Intervention: Placebo (430 mg olive oil/day)
Number of subjects: 89
Study 29330573 — intervention group
Group type: EXPERIMENTAL
Intervention: Low TT (430 mg TT/day, 70% purity)
Number of subjects: 89
Study 29330573 — intervention group
Group type: EXPERIMENTAL
Intervention: High TT (860 mg TT/day, 70% purity)
Number of subjects: 89
Study 26739235 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-tablets (MTs)
Number of subjects: 18
Study 26739235 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally disintegrating mini-tablet (ODMT)
Number of subjects: 18
Study 26739235 — intervention group
Group type: COMPARATOR
Intervention: Conventional tablet (CT)
Number of subjects: 18
Study 26739235 — intervention group
Group type: COMPARATOR
Intervention: Conventional orally disintegrating tablet (ODT)
Number of subjects: 18
Study 25365893 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent manipulation (performed at least 20 times per day and stimulation of the foot at least 100 times per day)
Number of subjects: 92
Study 25365893 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 92
Study 25365893 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent manipulation
Number of subjects: 92
Study 25365893 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 92
Study 25365893 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study 22479925 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermotherapy
Number of subjects: 382
Study 22479925 — intervention group
Group type: COMPARATOR
Intervention: Glucantime (5 days of intralesional administration)
Number of subjects: 382
Study 20229333 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi Qigong (TCQ) program, consisting of two 60‐min sessions each week for 3 months
Number of subjects: 206
Study 20229333 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (breathing techniques combined with walking)
Number of subjects: 206
Study 20229333 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 206
Study 17161911 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT) followed by interferon-alpha
Number of subjects: 6
Study 17161911 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha only
Number of subjects: 6
Study 15886836 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluor Protector and temporary crown
Number of subjects: 118
Study 15886836 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Or and temporary crown
Number of subjects: 118
Study 15886836 — intervention group
Group type: COMPARATOR
Intervention: Control group (only temporary crown)
Number of subjects: 118
Study 12119306 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy for bulimia nervosa
Number of subjects: 0
Study 12119306 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pharmacotherapy and short-term psychotherapy
Number of subjects: 0
Study 12119306 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized reporting practices
Number of subjects: 0
Study 9717330 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate for 24 hours
Number of subjects: 0
Study 9717330 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin plus gentamicin for 24 hours
Number of subjects: 0
Study 8023058 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene levels in patients (0.36 microgram/g biopsy)
Number of subjects: 131
Study 8023058 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol levels in patients (237.5 micrograms/g biopsy)
Number of subjects: 131
Study 8023058 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C supplement consumption
Number of subjects: 131
Study 2455151 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil SR (to 240 mg b.i.d.)
Number of subjects: 35
Study 2455151 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (to 100 mg b.i.d.)
Number of subjects: 35
Study 2455151 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 35
Study 29715073 — intervention group
Group type: EXPERIMENTAL
Intervention: GLoBE intervention (12-week exercise program)
Number of subjects: 94
Study 29715073 — intervention group
Group type: COMPARATOR
Intervention: Sham exercise (12-week exercise program)
Number of subjects: 94
Study 29715073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GLoBE and sham exercise programs
Number of subjects: 94
Study 27532880 — intervention group
Group type: EXPERIMENTAL
Intervention: MusicGlove therapy
Number of subjects: 17
Study 27532880 — intervention group
Group type: COMPARATOR
Intervention: Conventional tabletop exercises
Number of subjects: 17
Study 24166065 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT+RYGB
Number of subjects: 53
Study 24166065 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT+SG
Number of subjects: 53
Study 24166065 — intervention group
Group type: COMPARATOR
Intervention: IMT
Number of subjects: 53
Study 23325911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) intervention delivered by a nurse therapist, up to 12 sessions.
Number of subjects: 44
Study 23325911 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition with standard medical care (SMC).
Number of subjects: 44
Study 23325911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) intervention.
Number of subjects: 44
Study 21523723 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib (administered orally or via percutaneous feeding gastrostomy)
Number of subjects: 15
Study 21523723 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib (administered via percutaneous feeding gastrostomy)
Number of subjects: 15
Study 19907042 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization plus medical therapy
Number of subjects: 806
Study 19907042 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 806
Study 16951015 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoid
Number of subjects: 0
Study 16951015 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (topical retinoid + antimicrobial agent)
Number of subjects: 0
Study 16951015 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotics
Number of subjects: 0
Study 16951015 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoids (maintenance therapy)
Number of subjects: 0
Study 15234416 — intervention group
Group type: EXPERIMENTAL
Intervention: Tedisamil 0.4 mg/kg
Number of subjects: 201
Study 15234416 — intervention group
Group type: EXPERIMENTAL
Intervention: Tedisamil 0.6 mg/kg
Number of subjects: 201
Study 15234416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 11296434 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular lidocaine (Group I, n = 10)
Number of subjects: 41
Study 11296434 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-bursal lidocaine (Group II, n = 11)
Number of subjects: 41
Study 11296434 — intervention group
Group type: COMPARATOR
Intervention: No lidocaine (Group III, n = 10)
Number of subjects: 41
Study 11296434 — intervention group
Group type: COMPARATOR
Intervention: No lidocaine (Group IV, n = 10)
Number of subjects: 41
Study 9377539 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (10 mg doses)
Number of subjects: 12
Study 9377539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9377539 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 12
Study 8330468 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 28
Study 8330468 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 28
Study 6383055 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 139
Study 6383055 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 139
Study 30977770 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg/day or 75 mg/day)
Number of subjects: 104
Study 30977770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 26899588 — intervention group
Group type: EXPERIMENTAL
Intervention: Early medication change (EMC) strategy: venlafaxine XR for study days 15‐56; lithium augmentation for days 29‐56 if sustained non‐improvement on day 28.
Number of subjects: 192
Study 26899588 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU): continuation of escitalopram; non-responders on day 28 switched to venlafaxine XR for four weeks (days 29‐56).
Number of subjects: 192
Study 24548534 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention consisting of five monthly group educational sessions, two one-on-one visits, and follow-up phone calls over six months.
Number of subjects: 256
Study 24548534 — intervention group
Group type: COMPARATOR
Intervention: Introductory educational session only (Control group).
Number of subjects: 256
Study 23043818 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-aided walking in a Lokomat robotic trainer
Number of subjects: 8
Study 20197015 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of normal-dose telmisartan (40 mg) and low-dose hydrochlorothiazide (12.5 mg) once daily for 12 weeks
Number of subjects: 60
Study 17284896 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion technique for measuring glomerular filtration rate and renal plasma flow
Number of subjects: 44
Study 16899775 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg of atorvastatin per day
Number of subjects: 4731
Study 16899775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4731
Study 14749513 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine magnetic resonance (MR) imaging of the brain with a whole‐body 1.5‐T imager
Number of subjects: 9
Study 11044062 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed fluoroscopy at 15, 7.5, and 3.75 frames per second
Number of subjects: 70
Study 11044062 — intervention group
Group type: COMPARATOR
Intervention: Continuous fluoroscopy
Number of subjects: 70
Study 8834413 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 72
Study 1291703 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 26
Study 6377852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cronassial (12 patients)
Number of subjects: 25
Study 6377852 — intervention group
Group type: COMPARATOR
Intervention: Placebo (13 patients)
Number of subjects: 25
Study 28810433 — intervention group
Group type: EXPERIMENTAL
Intervention: non-expert group-delivered ultra-brief defusion and acceptance interventions
Number of subjects: 63
Study 28810433 — intervention group
Group type: COMPARATOR
Intervention: distraction control
Number of subjects: 63
Study 29199396 — intervention group
Group type: COMPARATOR
Intervention: Arm 1 (patient information)
Number of subjects: 2391
Study 29199396 — intervention group
Group type: COMPARATOR
Intervention: Arm 2 (links to educational materials for diagnosis and management of pain)
Number of subjects: 2391
Study 29199396 — intervention group
Group type: COMPARATOR
Intervention: Arm 3 (both patient information and links to educational materials)
Number of subjects: 2391
Study 29199396 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 4 (no communication)
Number of subjects: 2391
Study 25720557 — intervention group
Group type: COMPARATOR
Intervention: Concurrent neck dissection during TORS (control group)
Number of subjects: 41
Study 25720557 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged neck dissection 8.4 days after TORS (experimental group)
Number of subjects: 41
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m², thalidomide 100 mg, and dexamethasone 40 mg (VTD)
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib 1.3 mg/m², thalidomide 100 mg, and dexamethasone 40 mg with cyclophosphamide 400 mg/m² (VTDC)
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-induction combined CR/nCR rates
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-year overall survival
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3 to 4 adverse events (AEs)
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious AEs
Number of subjects: 98
Study 23091109 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life (EORTC QLQ-C30 Global Health score)
Number of subjects: 98
Study 21723605 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of donepezil (10 mg)
Number of subjects: 22
Study 21723605 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of donepezil (10 mg)
Number of subjects: 22
Study 21723605 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 22
Study 21723605 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 22
Study 21723605 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation
Number of subjects: 22
Study 19969215 — intervention group
Group type: EXPERIMENTAL
Intervention: Lotrafilcon A (Night & Day)
Number of subjects: 44
Study 19969215 — intervention group
Group type: COMPARATOR
Intervention: Lotrafilcon B (O(2)Optix)
Number of subjects: 44
Study 19969215 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of lenses
Number of subjects: 44
Study 17138308 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm intervention
Number of subjects: 215
Study 17138308 — intervention group
Group type: COMPARATOR
Intervention: Preterm control
Number of subjects: 215
Study 17138308 — intervention group
Group type: EXPERIMENTAL
Intervention: ELBW infants
Number of subjects: 215
Study 17138308 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 215